Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... over the second quarter 2009 as a result of a full quarter of sales of injectable Vancomycin, which launched in June 2009. The Company's net loss was approximately ...
2009 NOV 23 ... trial comparing the safety and efficacy of fidaxomicin (200 mg q12h) to that of oral vancomycin (125 mg q6h) in subjects suffering from CDI. This study, which enrolled 536 adult ...
2009 NOV 16 ... with iclaprim (3.5 mu g/ml), trimethoprim-sulfamethoxazole (TMP-SMX; 8/40 mu g/ml), vancomycin (40 mu g/ml), or saline, each of which was added one time for 48 h. In rat clots, ...
2009 NOV 16 ... to a study from Beijing, People's Republic of China, "The prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) among 1,012...
2009 NOV 16 ... study from the United States, "Many clinicians are trying unique strategies, including vancomycin and linezolid in combination, for treatment of patients who do not respond to ...
2009 NOV 23 ... According to recent research from the United States, "Vancomycin has been recommended as the treatment of choice for methicillin-resistant Staphylococcus ...
2009 NOV 23 ... and potentially lethal infection. Until recently, the only effective antibiotic was vancomycin, but the oxazolidinones, such as linezolid, have been shown to be a valuable addition to ...
2009 NOV 23 ... inpatient bed days were saved. The additional cost per day of OPAT was 167.60 euros. Vancomycin was the most prescribed antimicrobial, administered to 35%. Musculoskeletal infection ...
2009 NOV 16 ... According to recent research from Israel, "Vancomycin and teicoplanin are the glycopeptides currently in use for the treatment of infections ...
2009 NOV 17 ... with an ICD-9-CM code for CDI and to find documentation of CDI therapy with oral vancomycin or metronidazole. Laboratory and medical records were queried to identify symptomatic ...
2009 NOV 16 ... therapy was defined as receipt of daptomycin, linezolid, quinupristin-dalfopristin, or vancomycin within 1 calendar day after the first blood culture result positive for S. aureus (ie, ...
2009 NOV 16 ... PSSP. In the systemic MSSA and MRSA infections, LBM415 was equivalent to linezolid and vancomycin. In the systemic PSSP infection, LBM415 was equivalent to linezolid, whereas against ...
2009 NOV 23 ... into two groups: the first received postoperative monotherapy (with a beta-lactam or vancomycin), and the second received combination therapy (with an aminoglycoside for streptococcal ...
2009 NOV 16 ... 67 methicillin (meticillin)-resistant Staphylococcus aureus (MRSA) isolates. Twenty-six vancomycin-intermediate S. aureus ( VISA) strains were among the isolates tested; all strains were ...
2009 NOV 16 ... variants (SCVs) are extremely difficult to treat." "Daptomycin and vancomycin pharmacodynamics were evaluated against a site-directed hemB mutant of S. epidermidis ...
2009 NOV 16 ... "Upregulation of ccrA was observed upon exposure to beta-lactam antibiotics. Vancomycin increased ccrA expression in MW2 but had no effect on N315," wrote P.G. Higgins and ...
2009 NOV 16 ... obtained from patients with IE and to evaluate the in vitro activities of daptomycin and vancomycin alone and in combination with rifampin (rifampicin) or gentamicin while monitoring the ...
2009 NOV 16 ... "In a previous in vitro study, we showed that treatment with CAM and vancomycin (VCM) eradicated staphylococcal biofilms from surgical implants. To investigate the ...
2009 NOV 16 ... germs. A study conducted by the Henry Ford Hospital reported the USA600 strain resists Vancomycin, a drug successfully used in the past to treat patients with MRSA. "This ...
